AustralianSuper’s Gilead Sciences GILD Stock Holding History

AustralianSuper’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$200M	Sell	1,436,171 -1,131,067	-44%	-$158M	1.04%	19
2025 Q4	$315M	Sell	2,567,238 -466,851	-15%	-$56.7M	1.46%	9
2025 Q3	$337M	Sell	3,034,089 -343,966	-10%	-$39.1M	1.59%	9
2025 Q2	$375M	Buy	3,378,055 +320,348	+10%	+$34.1M	1.9%	8
2025 Q1	$343M	Buy	3,057,707 +1,919,438	+169%	+$198M	1.94%	9
2024 Q4	$105M	Buy	1,138,269 +5,989	+0.5%	+$539K	0.5%	57
2024 Q3	$94.9M	Buy	1,132,280 +115,594	+11%	+$8.82M	0.47%	63
2024 Q2	$69.8M	Buy	1,016,686 +610,012	+150%	+$40.7M	0.4%	69
2024 Q1	$29.6M	Buy	406,674 +175,136	+76%	+$13.5M	0.17%	83
2023 Q4	$18.8M	Buy	231,538 +31,742	+16%	+$2.47M	0.11%	109
2023 Q3	$15M	Sell	199,796 -9,054	-4%	-$696K	0.1%	112
2023 Q2	$16.1M	Buy	208,850 +186,528	+836%	+$14.9M	0.1%	119
2023 Q1	$1.85M	Buy	+22,322	New	+$1.85M	0.01%	173

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AustralianSuper's GILD Position: Q1 2026 in Review

AustralianSuper reduced its Gilead Sciences (GILD) stake by 44% in Q1 2026, selling an estimated $158M and leaving 1,436,171 shares worth $200M. The position accounts for 1.04% of the portfolio, ranked #19.

AustralianSuper first reported a position in GILD in Q1 2023 and has held it in 13 quarters since. The position peaked at $375M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

AustralianSuper held 1,436,171 shares of Gilead Sciences worth $200M as of Q1 2026.
AustralianSuper sold 1,131,067 Gilead Sciences shares in Q1 2026, an estimated $158M.
Gilead Sciences made up 1.04% of AustralianSuper's portfolio in Q1 2026, its #19 holding.
AustralianSuper first reported a position in Gilead Sciences in Q1 2023 and has held it in 13 quarters since.
AustralianSuper's Gilead Sciences position peaked at $375M in Q2 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.